DO THIS KIND OF DATA COLLECTION. SO WE DID NEED TO HAVE

SO WE DID NEED TO HAVE DIFFERENT, INNOVATIVE APPROACHES

DIFFERENT, INNOVATIVE APPROACHES TO DO IT.

TO DO IT. >> PLEASE EXPLAIN FOR THE RECORD

>> PLEASE EXPLAIN FOR THE RECORD AND FOR OUR AUDIENCE THE DANGER

AND FOR OUR AUDIENCE THE DANGER IN COMPARING THIS WITH

IN COMPARING THIS WITH INFLUENZA.

INFLUENZA. THE PRESIDENT HAS AGAIN POINTED

THE PRESIDENT HAS AGAIN POINTED OUT THE ANNUAL DEATH TOLL TO THE

OUT THE ANNUAL DEATH TOLL TO THE FLU AS IF TO INDICATE THAT

FLU AS IF TO INDICATE THAT ANYTHING LESS THAN THAT IS GREAT

ANYTHING LESS THAN THAT IS GREAT NEWS.

NEWS. >> WELL, YOU KNOW, FIRST OF ALL

>> WELL, YOU KNOW, FIRST OF ALL I’M NOT SURE IT’S GOING TO BE

I’M NOT SURE IT’S GOING TO BE LESS THAN THAT ONCE THIS FULLY

LESS THAN THAT ONCE THIS FULLY PLAYS OUT.

PLAYS OUT. WE’RE STILL LOOKING AT PROBABLY

WE’RE STILL LOOKING AT PROBABLY A CASE FATALITY RATE, BEST CASE

A CASE FATALITY RATE, BEST CASE SCENARIO, IN THE 0.5% RANGE,

SCENARIO, IN THE 0.5% RANGE, WHICH IS STILL SEVERAL FOLD

WHICH IS STILL SEVERAL FOLD HIGHER THAN THE TRADITIONAL FLU.

HIGHER THAN THE TRADITIONAL FLU. I DO THINK THIS IS SOMETHING

I DO THINK THIS IS SOMETHING DIFFERENT.

DIFFERENT. THIS IS SOMETHING TO WHICH

THIS IS SOMETHING TO WHICH PEOPLE HAVE NEVER HAD ANY CHANCE

PEOPLE HAVE NEVER HAD ANY CHANCE TO BUILD UP IMMUNITY.

TO BUILD UP IMMUNITY. THEY’VE NEVER BEEN EXPOSED.

THEY’VE NEVER BEEN EXPOSED. AND WHEN SOMETHING IS NEW AND

AND WHEN SOMETHING IS NEW AND DIFFERENT, THAT IS ALSO SCARENY

DIFFERENT, THAT IS ALSO SCARENY IN A DIFFERENT WAY BECAUSE IN

IN A DIFFERENT WAY BECAUSE IN PART WE AS SCIENTISTS DON’T HAVE

PART WE AS SCIENTISTS DON’T HAVE ALL THE ANSWERS.

ALL THE ANSWERS. >> WE’RE LEARNING ON THE FLY.

>> WE’RE LEARNING ON THE FLY. >> EXACTLY.

>> EXACTLY. WE’RE LEARNING ON THE FLY.

WE’RE LEARNING ON THE FLY. I DO THINK THAT’S A LITTLE BIT

I DO THINK THAT’S A LITTLE BIT DIFFERENT OF A SITUATION.

DIFFERENT OF A SITUATION. >> AND APPARENTLY IT’S SO

>> AND APPARENTLY IT’S SO VIRULENT THAT THE POINTS OF

VIRULENT THAT THE POINTS OF CONTACT YOU CAN INFECT AS AN

CONTACT YOU CAN INFECT AS AN ACTIVE FLU PATIENT ARE JUST A

ACTIVE FLU PATIENT ARE JUST A SMALL PORTION OF YOUR LEVEL OF

SMALL PORTION OF YOUR LEVEL OF CONTACT WITH THIS, CORRECT?

CONTACT WITH THIS, CORRECT? >> YEAH.

>> YEAH. YOU KNOW, IT DOES SEEM TO BE

YOU KNOW, IT DOES SEEM TO BE QUITE AN INFECTIOUS VIRUS.

QUITE AN INFECTIOUS VIRUS. SO THAT MAKES IT THAT MUCH MORE

SO THAT MAKES IT THAT MUCH MORE DIFFICULT TO CONTROL, ESPECIALLY

DIFFICULT TO CONTROL, ESPECIALLY SINCE SOME OF THE PEOPLE WHO MAY